Global Upfront Newspapers
Uncategorized

Oxford COVID-19 vaccine developer cautious on 2020 rollout

Possible vaccine still needs to be proven to work in late-stage trials

Thomson Reuters · Posted: Jul 21, 2020

Samples from coronavirus vaccine trials are handled inside the Oxford Vaccine Group laboratory in Oxford, England, on June 25. (John Cairns, University of Oxford/The Associated Press)

The University of Oxford’s possible COVID-19 vaccine could be rolled out by the end of the year but there is no certainty, the lead developer of the vaccine said on Tuesday.

The experimental vaccine, which has been licensed to AstraZeneca, produced an immune response in early-stage clinical trials, data showed on Monday, preserving hopes it could be in use by the end of 2020.

“The end-of-the-year target for getting vaccine rollout, it’s a possibility but there’s absolutely no certainty about that, because we need three things to happen,” Sarah Gilbert told BBC Radio.

She said it needed to be shown to work in late-stage trials, large quantities needed to be manufactured and regulators had to agree quickly to license it for emergency use before large numbers of people could be vaccinated.

Split opinions

England’s Chief Medical Officer Chris Whitty and his deputy, Jonathan Van-Tam, took differing views on the potential timeline.

“The chances of us getting a vaccine before Christmas that actually is highly effective are, in my view, very low,” Whitty told lawmakers.

Van-Tam, however, said he was “cautiously optimistic that we will have some vaccine this side of Christmas.”

The Oxford scientists had eyed a million doses of the potential vaccine to be produced by September.

Although the deal with AstraZeneca has provided manufacturing capacity to do that, the lower prevalence of the novel coronavirus in Britain has complicated the process of proving its efficacy.

Late-stage trials crucial for providing data are underway in Brazil and South Africa and are due to start in the United States.

There are no approved vaccines yet for COVID-19, but the World Health Organization has said AstraZeneca’s shot is one of the leading candidates.

Advertize With Us

See Also:

Bandits to Kaduna govt: Pay N100 million, 10 motorcycles ransom or 17 Greenfield University abducted students murdered by Tuesday

Global Upfront

Researchers say they’ve solved the puzzling mystery of the Moons of Mars

Global Upfront

Restrict access of youths to social media, says Bishop Oyedepo

Global Upfront

Reform of Defence sector will end insecurity in Nigeria, says Defence Minister, General Magashi

Global Upfront

Trump’s campaign chair worked closely with Russian operatives before and after 2016 elections, Republican-led panel says

Global Upfront

13 of the Least Healthy Fruits: Sugar, Diabetes, and More

Global Upfront

Oil pollution kills Ogoni people instalmentally – Dr Kabari

Global Upfront

Heart-song To The Iroko: Tackling The Designs Of Tony Akudinobi By Uzor Maxim Uzoatu

Global Upfront

Ripples as ISIS core restructures ISWAP into ISISAFRICA, appoints new leader, commanders

Global Upfront

Disgraced Canadian fertility doctor who used wrong sperm agrees to $13M settlement with families, including 17 ‘Barwin babies’

Global Upfront

This website uses Cookies to improve User experience. We assume this is OK...If not, please opt-out! Accept Read More